Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 26, 2024 9:11am
Antibe is over the barrel (binding arbitration)
the arbitrator has found in favor of Nuance Pharma in the dispute regarding the license agreement for the commercialization of otenaproxesul in the Greater China region. The confidential ruling from
...more
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Comment by
mstrmnds
on Mar 26, 2024 3:26am
RE:True Value
It's an additional cost to take the drug(s) to market but in the greater scheme of things it's a relatively small price to pay. The money wasn't even Antibe's (chronic indication
...more
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Post by
mstrmnds
on Mar 26, 2024 2:36am
True Value
If capital can significantly change the valuation of a company then what's the true valuation of a P2 company in acute pain with a disruptive lead drug?
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Mar 25, 2024 10:01am
Update 📉
looks like antibe wants to move lower. no news this morning, last week of the month!. it is white knuckle time for anyone invested. hopefully not an end of day friday news release, we know those are
...more
(4)
•••
FesticleShwartz
X
View Profile
View Bullboard History
Comment by
FesticleShwartz
on Mar 23, 2024 8:53am
RE:Update
Thanks for the update! Much appreciated
(6)
•••
Ryeman40
X
View Profile
View Bullboard History
Post by
Ryeman40
on Mar 22, 2024 7:56pm
Thanks
Forestview for updating the board with your conversations with Dan. We need more people who want to discuss facts about a company than would rather spew conjecture about said company. I've emailed
...more
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Mar 22, 2024 4:52pm
RE:RE:Update
If you lost trust, why are the only one making the most noise... sucks to suck huh
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Mar 22, 2024 3:14pm
RE:RE:RE:Update
that is right the 20mil us upfront money = 27.22M cdn, where are they going to find someone to help them pay there bills. and then the other 4M us on top of that. good luck to antibe
...more
(22)
•••
Forestview
X
View Profile
View Bullboard History
Comment by
Forestview
on Mar 22, 2024 2:52pm
RE:RE:Update
Wow. Duster, learn the difference between there and their, and loose and lose. So much bad grammar. And the $23.9M in the bank is in CDN. So, no, it won't cover Nuance. At
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Mar 22, 2024 1:08pm
RE:Update
i call B.S. on forestview good story though lol. my guess he got caught holding shares when the price dropped and now is in panic mode. i doubt nuance would gamble there 24Mil, if they did and
...more
(22)
•••
Forestview
X
View Profile
View Bullboard History
Post by
Forestview
on Mar 22, 2024 12:47pm
Update
Hey, so going to jump in since there's alot of speculation. And given that Duster is trying to drive down SP by spewing nonsense (again), I'll share some takeaways from a call I had with
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Mar 22, 2024 12:21pm
RE:RE:RE:RE:(News Release)
How are they going to keep the lights on at the antibe office let alone fund a P2 trial? Cash Position: As of December 31, 2023, the Company had available cash balance and term deposits
...more
(8)
•••
Montana5
X
View Profile
View Bullboard History
Comment by
Montana5
on Mar 22, 2024 11:02am
RE:RE:RE:(News Release)
An announcement that P2 has commenced (as was intended in Q1) would provide some confidence.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Mar 22, 2024 10:45am
RE:RE:(News Release)
of course management was trying to control the s.p. with there buying it eased share holder panic and the further sell-off of shares that was the message to investors. it buys them more time to raise
...more
(4)
•••
FesticleShwartz
X
View Profile
View Bullboard History
Comment by
FesticleShwartz
on Mar 22, 2024 7:47am
RE:RE:(News Release)
I do not think they will go bankrupt, sounds like we are in a holding pattern until September for funding and P3 acute. All is not lost hopefully
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >